Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters

被引:3
|
作者
Cohen, R. [1 ,2 ]
机构
[1] Hop Intercommunal Creteil, Microbiol Serv, F-94010 Creteil, France
[2] Assoc Clin & Therapeut Infantile Val Marne ACTIV, F-94010 Creteil, France
来源
ARCHIVES DE PEDIATRIE | 2008年 / 15卷
关键词
D O I
10.1016/S0929-693X(08)74216-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The progress in the knowledge of antibiotic action mechanism have led to determine phamacodynamic/pharmacokinetic (PK/PD) parameters predictive of antibiotic efficacy in bacterial infections. These parameters could vary according to the antibiotic compound, the bacterial specie implicated, the localization of the infection, the severity of the disease. The serum PK/PD parameters are predictive of efficacy in several infections (respiratory, skin, bone) and become a major criterion for selecting antibiotics in clinical practice. Moreover, these PK/PD parameters are the cornerstone of pre-clinical development of antibiotics, the determination of dosage and for the establishment of breakpoints for classifying strains in the sensitive or resistant area, (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S53 / S58
页数:6
相关论文
共 50 条
  • [41] Pharmacokinetic-pharmacodynamic modelling: History and perspectives
    Csajka, Chantal
    Verotta, Davide
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (03) : 227 - 279
  • [42] PHARMACOKINETIC-PHARMACODYNAMIC AND METABOLITE MODELING WITH TOPFIT
    TANSWELL, P
    HEINZEL, G
    WEISENBERGER, H
    ROTH, W
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1995, 33 (10) : 550 - 554
  • [43] Development of translational pharmacokinetic-pharmacodynamic models
    Mager, D. E.
    Jusko, W. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 909 - 912
  • [44] Pharmacokinetic-Pharmacodynamic Modeling of Propofol in Children
    Rigouzzo, Agnes
    Servin, Frederique
    Constant, Isabelle
    ANESTHESIOLOGY, 2010, 113 (02) : 343 - 352
  • [45] Pharmacokinetic-pharmacodynamic modeling of mivacurium in rats
    Troconiz, IF
    Garrido, MJ
    Garcia, E
    Suarez, E
    Calvo, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (02) : 252 - 256
  • [46] Methodological issues in pharmacokinetic-pharmacodynamic modelling
    Bellissant, E
    Sébille, V
    Paintaud, G
    CLINICAL PHARMACOKINETICS, 1998, 35 (02) : 151 - 166
  • [47] Pharmacokinetic-Pharmacodynamic Modelling of Danofloxacin in Turkeys
    A. M. Haritova
    N. V. Rusenova
    P. R. Parvanov
    L. D. Lashev
    J. Fink-Gremmels
    Veterinary Research Communications, 2006, 30 : 775 - 789
  • [48] Warfarin withdrawal - Pharmacokinetic-pharmacodynamic considerations
    Palareti, G
    Legnani, C
    CLINICAL PHARMACOKINETICS, 1996, 30 (04) : 300 - 313
  • [49] Pharmacokinetic-pharmacodynamic modeling of anticancer drug
    Park, IS
    Ahn, MR
    Suh, SK
    Choi, HS
    Sohn, SJ
    Kuh, HJ
    Yang, JS
    Yoo, TM
    DRUG METABOLISM REVIEWS, 2003, 35 : 28 - 28
  • [50] A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
    Ari Brekkan
    Luis Lopez-Lazaro
    Gunnar Yngman
    Elodie L. Plan
    Chayan Acharya
    Andrew C. Hooker
    Suresh Kankanwadi
    Mats O. Karlsson
    The AAPS Journal, 20